levodopa has been researched along with Daytime Sleepiness in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 22 (70.97) | 29.6817 |
2010's | 8 (25.81) | 24.3611 |
2020's | 1 (3.23) | 2.80 |
Authors | Studies |
---|---|
Kovrov, GV; Nodel, MR; Shevtsova, KV | 1 |
Gourdon, JC; Hamadjida, A; Huot, P; Nuara, SG | 1 |
Hagell, P; Horne, M; Iwarsson, S; Nilsson, MH; Odin, P; Rosqvist, K | 1 |
Ando, R; Choudhury, ME; Kannou, M; Kubo, M; Kyaw, WT; Nagai, M; Nishikawa, N; Nomoto, M; Tanaka, J; Yamanishi, Y | 1 |
Du, L; Lei, F; Li, Y; Sun, Y; Tang, X; Yang, L | 1 |
Auerbach, S; Cronin-Golomb, A; Durso, R; Harris, E; McNamara, P; Stavitsky, K | 1 |
Chaná, P | 1 |
Berrocal-Izquierdo, N; Castrillo-Sanz, A; Martínez-Pueyo, A; Rodríguez-Vico, JS | 1 |
Arnulf, I; Boniol, C; Clot, F; Decaix, C; Leu-Semenescu, S; Levy, R; Moussa, F; Roze, E; Touitou, Y; Vidailhet, M | 1 |
Daghem, M; Grosset, DG; Grosset, KA; Macphee, GJ; Newman, EJ; Nissen, T; Odin, P; Pal, G; Stewart, M | 1 |
Angrisano, S; Cicolin, A; Lopiano, L; Merola, A; Montanaro, E; Rizzi, L; Rizzone, M; Zibetti, M | 1 |
Rodrigues, RN; Silva, AA | 1 |
Aurilia, C; Barbanti, P; Fabbrini, G; Meco, G; Pauletti, C; Vanacore, N | 1 |
Onofrj, M; Stocchi, F; Vacca, L | 1 |
Brodsky, MA; Godbold, J; Olanow, CW; Roth, T | 1 |
de la Llave, Y; Garcia de Yébenes, J; Garcia-Borreguero, D; Larrosa, O; Schwarz, C | 1 |
Marciani, MG; Placidi, F; Romigi, A | 1 |
Cassel, W; Körner, Y; Krüger, HP; Meindorfner, C; Möller, JC; Oertel, WH; Rethfeldt, M; Rissling, I; Stiasny-Kolster, K | 1 |
Diem, A; Högl, B; Peralta, C; Poewe, W; Seppi, K; Wenning, GK | 1 |
Eberly, SW; Goetz, CG; Oakes, D; Schwid, SR; Shoulson, I | 1 |
Goldstein, R; Klein, C; Miniovitz, A; Pollak, L; Prokhorov, T; Rabey, JM; Shpirer, I; Theitler, J | 1 |
Blau, N; Friedman, J; Hyland, K; MacCollin, M | 1 |
Bliwise, DL; Rye, DB; Trotti, LM | 1 |
Barcena, J; Gómez-Esteban, JC; Jauregui, A; Lachen, MC; Lezcano, E; Rouco, I; Tijero, B; Ugarte, A; Velasco, F; Zarranz, JJ | 1 |
Biglan, KM; Holloway, RG; McDermott, MP; Richard, IH | 1 |
Marinus, J; van Hilten, JJ; van Rooden, SM; Verbaan, D; Visser, M | 1 |
Agapito, C; Bhattacharya, KF; Chaudhuri, KR; Pal, S | 1 |
Etminan, M; Rochon, PA; Samii, A; Takkouche, B | 1 |
Brandauer, E; Högl, B; Poewe, W; Seppi, K; Wenning, G | 1 |
Bartalini, S; Battistini, N; Giannini, F; Lombardi, C; Lugaresi, E; Passero, S; Rocchi, R; Rossi, S; Ulivelli, M | 1 |
Dewey, RB; O'Suilleabhain, PE | 1 |
4 review(s) available for levodopa and Daytime Sleepiness
Article | Year |
---|---|
[Advances in the medical treatment of Parkinson's disease].
Topics: Antiparasitic Agents; Disorders of Excessive Somnolence; Dopamine Agonists; Hallucinations; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease | 2009 |
[Dopaminergic stimulation in the non-motor symptoms of Parkinson's disease].
Topics: Autonomic Nervous System Diseases; Digestive System Diseases; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Levodopa; Mental Disorders; Parkinson Disease; REM Sleep Parasomnias; Sexual Dysfunction, Physiological; Sleep Apnea Syndromes; Urologic Diseases | 2010 |
Are there clinically significant differences between dopamine agonists.
Topics: Antiparkinson Agents; Clinical Trials as Topic; Disorders of Excessive Somnolence; Dopamine Agonists; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine | 2003 |
Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
Topics: Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; MEDLINE; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles | 2001 |
5 trial(s) available for levodopa and Daytime Sleepiness
Article | Year |
---|---|
Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Disorders of Excessive Somnolence; Drug Administration Routes; Drug Combinations; Duodenum; Female; Gastrostomy; Gels; Humans; Infusion Pumps, Implantable; Jejunum; Levodopa; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Parkinson Disease; Prospective Studies; Severity of Illness Index; Sleep Disorders, Intrinsic; Treatment Outcome | 2013 |
L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.
Topics: Aged; Antiparkinson Agents; Disorders of Excessive Somnolence; Double-Blind Method; Female; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Reaction Time; Selegiline | 2003 |
Comment on Shpirer et al. ("Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnographic study").
Topics: Aged; Antiparkinson Agents; Carbidopa; Disorders of Excessive Somnolence; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Polysomnography; Reaction Time; Statistics, Nonparametric | 2007 |
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.
Topics: Adult; Age Distribution; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cohort Studies; Comorbidity; Disorders of Excessive Somnolence; Double-Blind Method; Edema; Female; Hallucinations; Heart Diseases; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Risk Factors; Sex Distribution | 2007 |
Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): placebo-controlled, polysomnographic case report.
Topics: Aged; Cross-Over Studies; Disorders of Excessive Somnolence; Dopamine Agents; Double-Blind Method; Humans; Levodopa; Male; Multiple System Atrophy; Polysomnography; Sleep Stages | 2001 |
22 other study(ies) available for levodopa and Daytime Sleepiness
Article | Year |
---|---|
[The factors impact on the urgent daytime sleepiness degree in the Parkinson's disease].
Topics: Aged; Disorders of Excessive Somnolence; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine; Sleep Wake Disorders; Sleepiness | 2022 |
Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Behavior, Animal; Callithrix; Disorders of Excessive Somnolence; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Motor Activity; MPTP Poisoning; Parkinsonian Disorders; Serotonin Receptor Agonists; Trazodone | 2018 |
Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
Topics: Accelerometry; Aged; Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Depression; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesias; Female; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychotropic Drugs; Severity of Illness Index; Sweden | 2018 |
Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Arousal; Benzhydryl Compounds; Biogenic Monoamines; Disease Models, Animal; Disorders of Excessive Somnolence; Drug Therapy, Combination; Levodopa; Male; Mice, Inbred C57BL; Modafinil; Parkinson Disease; Photoperiod | 2018 |
Follow-up management of refractory continuous positive airway pressure therapy: emergent periodic limb movements in sleep.
Topics: Benserazide; Carbamazepine; Continuous Positive Airway Pressure; Disorders of Excessive Somnolence; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Polysomnography; Sleep Apnea, Obstructive | 2014 |
Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks.
Topics: Aged; Antiparkinson Agents; Brain; Cognition Disorders; Disorders of Excessive Somnolence; Dreams; Female; Functional Laterality; Hallucinations; Humans; Levodopa; Male; Nerve Net; Neuropsychological Tests; Parkinson Disease; Sleep, REM | 2008 |
Sleep and rhythm consequences of a genetically induced loss of serotonin.
Topics: 5-Hydroxytryptophan; Adult; Alcohol Oxidoreductases; Antidepressive Agents, Second-Generation; Consanguinity; Disorders of Excessive Somnolence; Dopamine; Dopamine Agents; Drug Therapy, Combination; Humans; Hydrocortisone; Hyperphagia; Levodopa; Male; Melatonin; Polysomnography; Serotonin; Sleep; Sleep Disorders, Circadian Rhythm | 2010 |
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Dizziness; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Time Factors | 2012 |
[Excessive daytime sleepiness after traumatic brain injury: association with periodic limb movements and REM behavior disorder: case report].
Topics: Antiparkinson Agents; Craniocerebral Trauma; Disorders of Excessive Somnolence; Humans; Levodopa; Male; Middle Aged; Periodicity; Polysomnography; Restless Legs Syndrome; Sleep Initiation and Maintenance Disorders; Sleep Stages | 2002 |
Excessive daytime sleepiness in de novo and treated Parkinson's disease.
Topics: Disorders of Excessive Somnolence; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2002 |
Sleepiness in Parkinson's disease: a controlled study.
Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Contraindications; Disorders of Excessive Somnolence; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sleep Stages; Surveys and Questionnaires | 2003 |
L-dopa-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.
Topics: Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Levodopa; Nocturnal Myoclonus Syndrome; Parkinson Disease; Predictive Value of Tests; Sleep Apnea, Obstructive | 2004 |
Daytime sleep latency in medication-matched Parkinsonian patients with and without sudden onset of sleep.
Topics: Aged; Case-Control Studies; Chi-Square Distribution; Disorders of Excessive Somnolence; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reaction Time; Sleep Stages | 2005 |
Levodopa-induced sleepiness in the Parkinson variant of multiple system atrophy.
Topics: Aged; Disorders of Excessive Somnolence; Dopamine Agents; Humans; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease | 2006 |
Safety of rasagiline in elderly patients with Parkinson disease.
Topics: Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Confusion; Disorders of Excessive Somnolence; Dopamine Agonists; Double-Blind Method; Female; Hallucinations; Humans; Hypotension, Orthostatic; Incidence; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Randomized Controlled Trials as Topic | 2006 |
Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzodiazepines; Clonazepam; Cohort Studies; Comorbidity; Disorders of Excessive Somnolence; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Reference Values; Restless Legs Syndrome; Sleep Stages; Wakefulness | 2006 |
Dopa-responsive hypersomnia and mixed movement disorder due to sepiapterin reductase deficiency.
Topics: Adult; Alcohol Oxidoreductases; Disorders of Excessive Somnolence; Female; Humans; Levodopa; Metabolic Diseases; Movement Disorders | 2006 |
Restless legs syndrome in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Comorbidity; Cross-Sectional Studies; Disability Evaluation; Disorders of Excessive Somnolence; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Quality of Life; Restless Legs Syndrome; Sick Role | 2007 |
Nighttime sleep problems and daytime sleepiness in Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Demography; Depressive Disorder; Disorders of Excessive Somnolence; Dyskinesias; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Risk Factors; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires | 2008 |
A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cabergoline; Disorders of Excessive Somnolence; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies; Thiazoles | 2001 |
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD.
Topics: Adult; Disorders of Excessive Somnolence; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Electroencephalography; Female; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep, REM; Wakefulness | 2002 |
Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease.
Topics: Aged; Analysis of Variance; Disorders of Excessive Somnolence; Dopamine Agents; Humans; Levodopa; Linear Models; Middle Aged; Parkinson Disease; Severity of Illness Index | 2002 |